Sciencast Management’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-31,540	Closed	-$66.9K	–	286
2023 Q3	$66.9K	Buy	+31,540	New	+$66.9K	0.03%	318